Male Reproduction COVID Sequelae Study (MARCOS).
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04665258|
Recruitment Status : Recruiting
First Posted : December 11, 2020
Last Update Posted : June 1, 2022
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||160 participants|
|Official Title:||Corona Virus Disease 19 (COVID-19) Vaccine and Impact on Fertility Study|
|Actual Study Start Date :||December 14, 2020|
|Estimated Primary Completion Date :||December 14, 2022|
|Estimated Study Completion Date :||December 14, 2022|
COVID-19 vaccine group
Participants scheduled to receive the COVID-19 vaccine will be evaluated on its effect on semen parameters for up to 6 months post vaccination.
- Sperm concentration [ Time Frame: up to 6 months ]As measured from semen samples.
- Sperm motility [ Time Frame: up to 6 months ]As measured from semen samples.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04665258
|Contact: Manuel Molina, MDfirstname.lastname@example.org|
|United States, Florida|
|University of Miami||Recruiting|
|Miami, Florida, United States, 33136|
|Contact: manuel molina, md 305-243-4873 email@example.com|
|Principal Investigator: Ranjith Ramasamy, MD|
|Principal Investigator:||Ranjith Ramasamy, MD||University of Miami|